SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 56.45-2.7%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (11924)6/5/2004 12:19:40 PM
From: Sam Citron  Read Replies (1) of 52153
 
Sorry if I did not adequately express my gratitude and to be "all take and no give", but I frankly have so little experience or background in biotech investing or medicine or science that it is simply my nature to ask questions. I would be very happy to give if the question is within the domain of my knowledge or experience. I have been an investor for 35 of my 51 years, so I know a little bit about the stock market in general. I have a BA in economics from Harvard, where my focus was on economic development of India, and I have a JD from UC Davis (professional focus was elder law). Current focus is on my one and three year old children.

A very big TIA if someone can tell me what factors are normally considered in a milestone negotiation and whether the milestone payment is indicative of what the drug might be worth.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext